These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 15324475)
1. A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence. Sawicka M; Kalinowska M; Skierski J; Lewandowski W J Pharm Pharmacol; 2004 Sep; 56(9):1067-81. PubMed ID: 15324475 [TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Zhang D; Fan D Expert Rev Anticancer Ther; 2007 Oct; 7(10):1369-78. PubMed ID: 17944563 [TBL] [Abstract][Full Text] [Related]
3. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in P-glycoprotein-mediated multidrug resistance reversal mechanisms. Li X; Li JP; Yuan HY; Gao X; Qu XJ; Xu WF; Tang W Methods Find Exp Clin Pharmacol; 2007 Nov; 29(9):607-17. PubMed ID: 18193112 [TBL] [Abstract][Full Text] [Related]
5. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954 [TBL] [Abstract][Full Text] [Related]
6. The great multidrug-resistance paradox. Chen VY; Rosania GR ACS Chem Biol; 2006 Jun; 1(5):271-3. PubMed ID: 17163753 [TBL] [Abstract][Full Text] [Related]
7. Integrins and extracellular matrix: a novel mechanism of multidrug resistance. Elliott T; Sethi T Expert Rev Anticancer Ther; 2002 Aug; 2(4):449-59. PubMed ID: 12647988 [TBL] [Abstract][Full Text] [Related]
8. Modulation of P-glycoprotein-mediated multidrug resistance in K562 leukemic cells by indole-3-carbinol. Arora A; Seth K; Kalra N; Shukla Y Toxicol Appl Pharmacol; 2005 Feb; 202(3):237-43. PubMed ID: 15667829 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms and functional aspects of multidrug resistance in Ehrlich ascites tumour cells. Nielsen DL Dan Med Bull; 2004 Nov; 51(4):393-414. PubMed ID: 16009064 [No Abstract] [Full Text] [Related]
10. Targeted chemotherapy in drug-resistant tumors, noninvasive imaging of P-glycoprotein-mediated functional transport in cancer, and emerging role of Pgp in neurodegenerative diseases. Sivapackiam J; Gammon ST; Harpstrite SE; Sharma V Methods Mol Biol; 2010; 596():141-81. PubMed ID: 19949924 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biochemical characterization of new phenothiazines and related drugs as MDR reversal agents. Schmidt M; Teitge M; Castillo ME; Brandt T; Dobner B; Langner A Arch Pharm (Weinheim); 2008 Oct; 341(10):624-38. PubMed ID: 18816589 [TBL] [Abstract][Full Text] [Related]
12. Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract. Fong WF; Wang C; Zhu GY; Leung CH; Yang MS; Cheung HY Phytomedicine; 2007 Feb; 14(2-3):160-5. PubMed ID: 16713217 [TBL] [Abstract][Full Text] [Related]
13. (+/-)-3'-O, 4'-O-dicynnamoyl-cis-khellactone, a derivative of (+/-)-praeruptorin A, reverses P-glycoprotein mediated multidrug resistance in cancer cells. Shen X; Chen G; Zhu G; Fong WF Bioorg Med Chem; 2006 Nov; 14(21):7138-45. PubMed ID: 16875827 [TBL] [Abstract][Full Text] [Related]
14. [Resistance of hematologic neoplasm cells to cytostatics. Part II]. Kodydková K; Krejsek J Cas Lek Cesk; 2000 Sep; 139(19):591-5. PubMed ID: 11192750 [TBL] [Abstract][Full Text] [Related]
15. Multidrug resistance in cancer. Baguley BC Methods Mol Biol; 2010; 596():1-14. PubMed ID: 19949917 [TBL] [Abstract][Full Text] [Related]
16. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells. Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489 [TBL] [Abstract][Full Text] [Related]
17. Effect of Stemona curtisii root extract on P-glycoprotein and MRP-1 function in multidrug-resistant cancer cells. Limtrakul P; Siwanon S; Yodkeeree S; Duangrat C Phytomedicine; 2007 Jun; 14(6):381-9. PubMed ID: 17467965 [TBL] [Abstract][Full Text] [Related]
18. Isomeric N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent P-glycoprotein (Pgp)-dependent multidrug resistance (MDR) inhibitors. Teodori E; Martelli C; Salerno M; Darghal N; Dei S; Garnier-Suillerot A; Gualtieri F; Manetti D; Scapecchi S; Romanelli MN J Med Chem; 2007 Feb; 50(4):599-602. PubMed ID: 17256837 [TBL] [Abstract][Full Text] [Related]
19. Evolutionary malignant resistance of cells to damaging factors as common biological defence mechanism in neoplastic development. Review of conception. Monceviciute-Eringiene E J Exp Clin Cancer Res; 2000 Sep; 19(3):335-48. PubMed ID: 11144527 [TBL] [Abstract][Full Text] [Related]
20. Expression of multidrug resistance-related proteins p-glycoprotein, glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K Hepatogastroenterology; 2008; 55(86-87):1530-6. PubMed ID: 19102336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]